Skip to main content
. Author manuscript; available in PMC: 2021 Mar 8.
Published in final edited form as: J Rheumatol. 2019 Jul 1;47(8):1267–1274. doi: 10.3899/jrheum.190162

Figure 2.

Figure 2.

A. Pie chart depicting the percent of clinically confirmed patients enrolled in the study and followed up with 20 months post-CHIKV infection (n = 485) who reported persistent joint pain at 20 months (20 m) and 40 months (40 m) after infection. B. Graph showing percent of patients with persistent joint pain 40 months post-infection who reported at least moderate problems within each area of daily life. Patients were 3 times as likely to report problems with pain and discomfort than problems in any other area. CHIKV: chikungunya virus.